Food Science & Technology · Product, Health & Industry · also Alternative Proteins, Future Foods, Plant-based Foods, Cellular Agriculture
The newest part of the field: plant-based meat, dairy and egg analogues, cultivated meat, precision-fermentation ingredients, mycoprotein, insects and algae, and 3D food printing — their technology, nutrition, safety, regulation and sustainability claims.
In the exams: ICAR AICE 35.a Unit 2 (dairy analogues based on plant milk); PG research and industry R&D roles
Alternative proteins are foods that supply protein from sources other than conventional livestock and fisheries, or that replace animal-derived ingredients with ones made in new ways. The field includes plant-based analogues of meat, milk, cheese and egg; fungal biomass such as mycoprotein; ingredients made by precision fermentation, in which microorganisms are engineered to produce specific animal proteins or fats; cultivated (cell-based) meat grown from animal cells; edible insects; algae and seaweeds; and enabling technologies such as high-moisture extrusion and 3D food printing. Some of these, such as tofu, tempeh, seitan, seaweeds and insects, are old foods in many cultures; others are only a few years from the laboratory.
This manual explains the technology of each route, what is known about the nutrition and safety of the products, how they are regulated, and how their environmental claims are assessed. It is a fast-moving field, so the manual states well-established principles and dates any regulatory or market fact; figures for environmental impact are given as ranges that depend on the life-cycle assessment behind them, not as single definitive numbers. Plant protein extraction and functionality are covered in pulses-oilseeds-plant-proteins, extrusion engineering in extrusion-technology, additives such as methylcellulose and colours in food-additives-ingredients, health claims in functional-foods-nutraceuticals, allergens and toxicants in food-toxicology-contaminants-allergens, the general regulatory system in food-law-regulatory-affairs and the microbiology of fermentation in fermentation-food-biotechnology.
Formal examinations touch this subject only lightly: national postgraduate food science entrance examinations and research fellowship examinations ask about plant proteins, textured vegetable protein and dairy analogues based on plant milk. It is mainly postgraduate research and industry research and development content, important for anyone who will work on product development, regulation or sustainability in the protein sector.
Several pressures drive interest in alternative proteins. World population and incomes are rising, and with them demand for animal-source foods, especially in Asia and Africa. Livestock production uses a large share of agricultural land, contributes a substantial share of anthropogenic greenhouse gas emissions (estimates differ with method and year), and is linked to water use, nutrient pollution, deforestation and biodiversity loss. Intensive livestock production raises concerns about antimicrobial resistance and zoonotic disease, and many consumers are concerned about animal welfare. At the same time, animal-source foods are dense sources of high-quality protein, iron, zinc, vitamin B12 and other nutrients, and for many people in low-income countries more, not less, animal-source food would improve nutrition.
The drivers therefore differ between settings. In high-income countries the main arguments are environmental, ethical and health-related reduction of meat consumption; in other settings they include affordable protein, resilience of supply and use of local crops. Alternative proteins are one response; others include reducing food waste, improving the efficiency of livestock systems, and shifting diets toward more legumes, grains and vegetables, which are themselves the oldest alternative proteins.
The sector is usually divided into three technology groups. Plant-based products use proteins from soy, pea, wheat, faba bean, chickpea, mung bean, oats, rice and other crops, structured and formulated to resemble meat, milk, cheese or egg. Fermentation-derived products include biomass fermentation (growing microorganisms such as fungi or microalgae for their whole biomass), precision fermentation (producing specific molecules with engineered microorganisms) and traditional fermentation used to improve flavour and texture. Cultivated meat is grown from animal cells in bioreactors. Insects and algae are often treated as separate groups. Hybrid products combine these routes, for example plant-based products with precision-fermented fat or cultivated cells.
Sales of plant-based analogues grew quickly in some markets in the late 2010s and then flattened or fell in several of them, showing that taste, price, texture and perceptions of processing matter as much as environmental arguments. Market figures change year to year and differ by source, so a technologist should treat any market statistic as dated and source-specific.
Every alternative protein claim invites the same set of questions, and the rest of this manual returns to them. What is the product's nutritional value, in terms of protein quality (digestibility and amino acid profile) and micronutrients, compared with the food it replaces? Is it safe, including allergens, anti-nutrients, contaminants, microbial hazards and the novelty of the process? Is it permitted, and under which regulatory pathway, in the target market? What does it really cost, at scale, and can it be made with available equipment and supply chains? Do consumers accept it, in taste, texture, price and cultural meaning? And is it actually better for the environment, according to a transparent life-cycle assessment with a sensible functional unit, compared with realistic alternatives? An honest answer often differs by product and by country, and some answers are not yet known for the newest technologies. These questions also apply to the comparison product: a fair evaluation compares an alternative with the realistic food it replaces in a given diet and place, not with the worst or best example of that food.
Plant-based meat analogues are built from a protein base, fat, binders, flavour and colour. The protein provides structure and nutrition. Soy and wheat gluten are the traditional bases; pea protein has become widely used, and faba bean, chickpea, mung bean, rapeseed (canola) and potato proteins are increasingly used. Protein isolates (commonly around 80–90% protein) and concentrates (commonly around 50–70%) are obtained by wet or dry fractionation, covered in pulses-oilseeds-plant-proteins; their functionality (solubility, water and oil binding, gelation, emulsification) depends on how they were extracted and dried. Fats, often coconut oil, shea or other vegetable fats chosen for their melting behaviour, mimic the marbling and juiciness of animal fat; structured emulsions and oleogels are used to reduce saturated fat. Binders such as methylcellulose, which gels on heating and gives cohesion and bite, starches and fibres hold the product together. Flavour comes from yeast extracts, reaction flavours, spices and, in some products, haem proteins such as soy leghaemoglobin made by fermentation; red colour that browns on cooking comes from beetroot juice or similar colourants. Additives are covered in food-additives-ingredients.
The fibrous texture of whole-muscle meat is the hardest feature to reproduce. The main industrial method is extrusion. Low-moisture extrusion, at moisture contents commonly below about 30–40%, produces textured vegetable protein (TVP): expanded, porous pieces that are dried and later rehydrated, used in mince-type products. High-moisture extrusion, at moisture contents commonly above about 40–50%, heats and shears protein in the barrel and then passes it through a long cooling die, where the protein melt aligns and solidifies into an anisotropic, fibrous structure resembling cooked chicken or meat, without expansion. The fibre formation depends on protein type, moisture, temperature, screw speed and die design. Extrusion engineering is covered in extrusion-technology. Process variables interact. Higher moisture gives softer, more layered products; higher barrel temperature increases protein crosslinking and firmness; and the protein blend matters, because gluten, soy and pea proteins form fibres differently. Small changes in raw-material protein content or particle size can change texture markedly, so ingredient specifications and in-line monitoring of torque, pressure and temperature are used to keep the product consistent from batch to batch.
Other structuring routes include shear cell technology, in which protein dough is sheared between a rotating and a stationary cylinder (Couette cell) while heated, giving long fibrous structures; spinning and wet-spinning of protein fibres; freeze structuring; and 3D printing (chapter 9). Combining structured fibres with fat and binder in a forming or layering step gives whole-cut products.
Product quality is judged by texture (instrumental texture profile analysis and sensory panels, comparing hardness, springiness, chewiness and fibrousness with the meat target), juiciness and cooking loss, colour change on cooking, flavour, and absence of off-flavours. Off-flavours from legume proteins, such as beany and grassy notes from lipid oxidation products (for example hexanal) and bitterness from saponins and peptides, are a major challenge; they are reduced by variety selection, processing and masking. Nutritional design includes protein content and quality, sodium (often high in processed analogues), saturated fat, and fortification with vitamin B12, iron and zinc, whose bioavailability from plant matrices may be lower than from meat.
Plant-based drinks, often marketed as milks, are made by soaking and wet-milling or extracting legumes, cereals, nuts or seeds in water, separating the insoluble fibre, formulating with oil, sugar, salt, stabilisers and micronutrients, homogenising and heat treating, usually by UHT. Soy drink has a protein content close to cow milk; drinks made from almonds, rice, coconut and most oats are much lower in protein. Oat drinks are made by enzymatic hydrolysis of oat starch with amylases, which thins the slurry and produces sugars that give natural sweetness; β-glucan contributes viscosity. Pea-protein drinks use pea isolate to raise protein. Unless fortified, plant drinks contain little calcium, vitamin D, vitamin B12, riboflavin or iodine compared with cow milk, and the bioavailability of added calcium depends on the salt used and on keeping it suspended. Their protein quality is lower than that of milk protein for most bases. Whether a plant drink may be called 'milk' is a legal question that different jurisdictions answer differently; the European Union, for example, generally reserves dairy terms for products of animal milk, with listed exceptions.
Cheese analogues are among the hardest to make well, because the stretch, melt and flavour of dairy cheese come from casein and its interaction with calcium and fat. Many current cheese analogues are emulsions of coconut oil or other solid fats with starches, which give firmness and some melt but little protein. Others are made by fermenting nut (often cashew) or soy bases with lactic cultures and ripening them, which gives cheese-like flavour but a different texture. Producing casein by precision fermentation (chapter 5) is seen as a route to true stretch and melt. Plant-based yoghurts are fermented soy, oat, coconut or almond bases with yoghurt cultures or other lactic acid bacteria, thickened with starches, pectin or proteins because plant proteins do not gel as casein does. Plant cheeses and yoghurts are usually much lower in protein and calcium than their dairy counterparts unless formulated otherwise, and their labels and nutrition panels should make this clear to consumers who use them as direct substitutes.
Egg performs many functions: foaming and aeration, emulsification, coagulation and binding on heating, colour and flavour. No single plant ingredient replaces all of them. Scrambled-egg analogues have been made from mung bean protein isolate, which coagulates on heating; aquafaba, the cooking liquid of chickpeas, contains proteins and saponins that foam and can replace egg white in meringues and mousses; methylcellulose, starches and gums provide binding; lecithin and plant proteins emulsify; and carotenoid colourants and black salt (kala namak, with sulphur compounds) imitate colour and flavour. Egg replacers for bakery are blends tailored to the function egg performs in that product. Nutritionally, egg analogues usually differ from egg in protein quality, choline and vitamin content unless fortified, and they carry their own allergen profile. In industrial bakery, replacing egg is often driven by cost, supply disruptions from avian influenza and allergen management as much as by vegan demand, and partial replacement, keeping some egg while substituting the rest, is common because it preserves most of the product's quality.
Mycoprotein is the biomass of the filamentous fungus Fusarium venenatum grown in continuous fermentation on a glucose-based medium with a nitrogen source. It was developed in the United Kingdom from the 1960s onward, approved for food there in the 1980s after extensive safety testing, and has been sold since in several countries. The fungus is grown in airlift fermenters, where air rising through the broth both aerates and mixes it. The fungal hyphae give a naturally fibrous texture resembling meat, which is a major advantage over plant proteins that must be structured mechanically.
Fungal biomass grown quickly has a high RNA content, which in large amounts raises uric acid and could cause gout, so the harvested biomass is heat-treated to activate the fungus's own ribonucleases and reduce RNA to an acceptable level before it is concentrated. The biomass is then dewatered, mixed with a binder (originally egg albumen; plant-based binders in vegan versions), formed, steamed and chilled or frozen. Mycoprotein is high in protein and fibre (including chitin and β-glucans from the cell walls) and low in fat. A small number of consumers react to it, so labelling identifies it.
Other filamentous fungi used for food biomass include species of Neurospora (the mould of the Indonesian fermented food oncom), Aspergillus and Rhizopus, which is the mould of tempeh. Solid-state fermentation grows fungi on cooked grains, legumes or by-products, binding them into cakes, as in tempeh and oncom; submerged fermentation grows them in liquid media and harvests the mycelium. Fungal mycelium can also be grown as mats on the surface of liquid media. These routes use agricultural side-streams such as brewers' spent grain or starch processing residues as substrates, which can improve their environmental performance.
Yeasts and bacteria grown as single-cell protein (SCP) on methanol, natural gas, carbon dioxide and hydrogen, or agricultural residues have a long history in animal feed and are being developed again for food. They share the high-RNA issue and need processing to reduce nucleic acids and to separate or disrupt cells. Food uses of any new microbial biomass require safety assessment of the strain (absence of toxins, allergens and pathogenicity) and of the process under novel food or equivalent rules.
Biomass fermentation has engineering features in common with other industrial fermentations, covered in fermentation-food-biotechnology. Productivity depends on the specific growth rate, cell density and yield of biomass on substrate; continuous culture at a dilution rate below the maximum growth rate keeps cells growing steadily. Oxygen transfer limits growth of aerobic organisms at high density, so fermenter design (airlift or stirred tank), aeration and cooling are central. Sterility must be maintained, because contaminants compete and may be harmful. Downstream processing (separation, RNA reduction, dewatering, texturising) adds cost and energy. The protein yield of a process can be calculated from biomass yield and protein content: 1000 kg of wet biomass at 25% dry matter containing 45% protein on a dry basis holds 1000 × 0.25 × 0.45 = 112.5 kg of protein. Continuous fermentation needs careful control of contamination and of strain stability over long runs, and the economics depend on the cost of the carbon source, aeration energy and capital cost of large sterile vessels, all of which differ by location.
Precision fermentation uses microorganisms, commonly yeasts such as Komagataella phaffii (formerly Pichia pastoris) and Saccharomyces cerevisiae, filamentous fungi such as Trichoderma reesei and Aspergillus species, or bacteria, engineered with a gene that codes for a target molecule, such as a milk protein, egg protein, haem protein, sweet protein, enzyme or fat. The microorganism is grown in a fermenter, produces and often secretes the target, and the product is separated and purified so that the final ingredient contains the molecule but not the production organism. The approach is not new in food: chymosin for cheese making has been produced this way since the early 1990s and now supplies most of the world's cheese rennet, and many food enzymes, vitamins and flavour compounds are made by fermentation.
Current food targets include whey proteins such as β-lactoglobulin, casein proteins (which must also be phosphorylated and assembled with calcium into micelle-like structures to behave like casein), egg white proteins such as ovalbumin, soy leghaemoglobin for meat-like flavour and colour, collagen and gelatin, sweet proteins, and structured fats and human milk oligosaccharides for infant formula.
The process has upstream, fermentation and downstream stages. Upstream, strains are engineered and optimised for titre (grams of product per litre), rate and yield on sugar. Fermentation runs in fed-batch or continuous mode with controlled feeding, aeration, pH and temperature. Downstream, cells are removed by centrifugation or filtration, and the product is purified by precipitation, membrane filtration, chromatography or crystallisation and then dried. Downstream processing commonly accounts for a large share of the cost.
The main challenges are cost and scale: food proteins sell at prices far below pharmaceutical proteins, so titres, yields and plant sizes must be very high, and global fermentation capacity for food-grade products is limited. Functionality may differ from the animal protein, because animal proteins carry modifications, such as glycosylation and phosphorylation, that microorganisms perform differently or not at all. Regulatory assessment covers the identity and purity of the product, the absence of the production organism and its DNA where required, allergenicity (a precision-fermented milk protein is still a milk allergen and must be labelled as such) and the safety of the strain.
Cultivated meat, also called cell-based or cultured meat, is produced by growing animal cells outside the animal and assembling them into food. The cells are muscle stem cells (satellite cells), fibroblasts, fat precursor cells (pre-adipocytes) or pluripotent stem cells taken from a biopsy of a living animal, a fertilised egg or an embryo. Primary cells divide only a limited number of times before they senesce, so producers seek cell lines that proliferate indefinitely. These may arise spontaneously, be selected in culture, or be immortalised by genetic modification (for example by expressing telomerase), which raises its own regulatory and consumer questions. Cells are expanded in bioreactors and then differentiated into muscle fibres or fat cells, or harvested as a mass of cells. Growth follows exponential kinetics: from 1 million to 16 million cells per millilitre is four doublings, which at a doubling time of 24 hours takes about 96 hours. Even fast-growing mammalian cells divide far more slowly than microorganisms, which is one root of the cost problem.
Cells need a culture medium with glucose, amino acids, vitamins, salts, buffers and growth factors and hormones. Historically, research used fetal bovine serum (FBS), which is costly, variable, raises welfare concerns and contradicts the aim of removing animals from production, so serum-free media have been developed using recombinant growth factors such as fibroblast growth factor 2, insulin, transferrin and others. Growth factors made by precision fermentation are the most expensive components, and reducing their cost, by cheaper production, more stable forms or cell lines that need fewer of them, is a major research goal. Food-grade rather than pharmaceutical-grade ingredients, recycling of media and use of plant hydrolysates are being studied. Because animal cell cultures have no defences against microbial contamination and producers aim to avoid antibiotics, strict aseptic operation is essential. Media components must also be food-grade and free of substances that could leave unsafe residues, and the spent medium, which contains ammonia and lactate produced by the cells, must be treated or recycled. The large volumes of water and energy for media preparation and sterilisation are part of the environmental footprint.
Unstructured products such as minced or processed items can be made from cell mass, often blended with plant ingredients; whole cuts need scaffolds, edible or degradable structures to which cells attach, on which they align and through which nutrients and oxygen can reach them. Candidate scaffolds include plant-derived materials (decellularised plant tissues, textured plant protein), polysaccharide or protein hydrogels and microcarriers for expanding adherent cells in stirred tanks. Thick tissues need a way to supply oxygen and nutrients throughout, because diffusion alone reaches only a fraction of a millimetre. Bioreactors under study include stirred tanks, airlift reactors, perfusion and hollow-fibre systems; the largest food-scale volumes remain far smaller than those of microbial fermentation.
As of 2026, Singapore was the first country to approve cultivated meat for sale, in 2020 (a chicken product, initially containing a large proportion of plant ingredients). The United States cleared cultivated chicken from two producers in 2023 under a joint FDA–USDA framework, and Israel approved a cultivated beef product in 2024. Several jurisdictions, including some US states and Italy, have restricted or banned its sale. Volumes sold remain very small, and production cost at scale is unresolved.
Insects are traditional foods for very large numbers of people in Africa, Asia and Latin America; the FAO's 2013 report on edible insects drew wide attention to their potential. Commonly farmed species for food and feed include the house cricket (Acheta domesticus), the yellow mealworm (larva of Tenebrio molitor), the lesser mealworm, the migratory locust and, mainly for feed, the black soldier fly (Hermetia illucens), whose larvae can be reared on organic side-streams. Insects are eaten whole, as roasted or fried snacks, or processed into powders and protein fractions.
Their protein content is commonly reported in a wide range, from about a third to over half of dry matter depending on species, life stage and diet, and they supply fat, minerals such as iron and zinc, and some vitamins. Part of the nitrogen is in chitin, the polysaccharide of the exoskeleton, so protein estimated as total nitrogen × 6.25 overstates true protein; lower conversion factors have been proposed. Chitin also reduces digestibility unless removed or broken down.
Insects are cold-blooded and many can be reared at high density on feed that people do not eat, so they can convert feed to edible mass more efficiently than warm-blooded livestock, and a larger share of the body is edible. A simple comparison from given data illustrates the point: if crickets need 2.1 kg of feed per kg live weight with 80% edible, 10 kg of edible cricket needs 10 ÷ 0.8 × 2.1 = 26.3 kg of feed, while cattle at 8.0 kg feed per kg live weight with 40% edible need 10 ÷ 0.4 × 8.0 = 200 kg. Real feed conversion ratios vary widely with species, diet, temperature and farm, and the environmental advantage depends on what the insects are fed and on the energy used for heating and processing; when insects are fed on high-quality feed that could feed livestock or people, the advantage shrinks. Life-cycle studies give a range of results.
Insect foods raise specific safety issues. Allergy: insects contain tropomyosin and arginine kinase, which cross-react with crustacean and house dust mite allergens, so people allergic to shellfish may react, and labels in several jurisdictions carry warnings. Microbial hazards: insects carry a high gut microbial load, so they are fasted, blanched or otherwise heat-treated and handled hygienically. Chemical hazards: heavy metals, pesticide residues and mycotoxins can accumulate from substrates, so feeding substrates are controlled, and some substrates permitted for other animals, such as manure, are prohibited for food insects in many jurisdictions. Some species and life stages can contain natural toxins.
In the European Union insects are novel foods; the dried yellow mealworm was the first authorised, in 2021, followed by other species and forms. Other countries, such as Thailand, have their own rules and long traditions of insect eating. Consumer acceptance in countries without that tradition remains a major barrier, often addressed by selling insects as invisible powders in familiar foods.
Microalgae and cyanobacteria are grown in open ponds or closed photobioreactors, or, for some species, heterotrophically in fermenters on sugars. Spirulina (Arthrospira, strictly a cyanobacterium) has been harvested from lakes in Chad and Mexico for centuries and is now farmed widely; it is rich in protein, commonly around 60% of dry weight, and contains the blue pigment phycocyanin, used as a natural blue food colour. Chlorella is a green microalga with a tough cell wall that must be disrupted for good digestibility. Heterotrophic microalgae such as Schizochytrium are the main commercial source of DHA, the long-chain omega-3 fatty acid, for infant formula and vegetarian supplements, covered in functional-foods-nutraceuticals. Microalgae also supply carotenoids such as astaxanthin and β-carotene.
As protein sources microalgae face high production cost, energy for harvesting and drying very dilute cultures, strong colour and flavour, and digestibility limits. Contamination by toxin-producing cyanobacteria (microcystins) in open-pond products is a known safety concern requiring testing, and heavy metals must be controlled.
Seaweeds (macroalgae) are traditional foods in East Asia and coastal communities worldwide: nori (Porphyra and Pyropia), kombu and kelp (Saccharina, Laminaria), wakame (Undaria), dulse (Palmaria) and many others. They are farmed at very large scale in China, Indonesia, the Philippines, Korea and Japan, and harvested from the wild elsewhere. Seaweeds supply minerals, iodine, dietary fibre and, in red seaweeds such as nori, notable protein; their protein is partly bound up with polysaccharides and polyphenols, limiting digestibility. They are the source of the hydrocolloids agar, carrageenan and alginate, covered in food-additives-ingredients.
Safety issues include very high and variable iodine content in brown seaweeds such as kelp, which can cause thyroid problems if eaten regularly in large amounts, and inorganic arsenic, notably in hijiki, which several food safety authorities advise against eating. Heavy metals such as cadmium and lead reflect growing waters. Seaweed farming needs no fresh water, land or fertiliser and is promoted for its low environmental footprint, though impacts depend on scale and location.
Three-dimensional (3D) food printing builds a food object layer by layer from a digital design. The most common method for food is extrusion-based printing, in which a paste, gel or melt is pushed through a nozzle by a piston, screw or air pressure while the nozzle moves along programmed paths. Other methods include selective sintering or binding of powders (used for sugar and some confectionery) and inkjet printing for decoration. For an extrusion printer, the volumetric flow the nozzle must deliver equals the cross-section of the printed line multiplied by the print speed: a 1.2 mm wide line with a 1.0 mm layer height printed at 20 mm/s needs about 1.2 × 1.0 × 20 = 24 mm³ of material per second.
A material is printable if it flows through the nozzle under pressure but holds its shape once deposited and supports the layers above. This requires shear-thinning behaviour, a yield stress, and fast recovery of structure after extrusion, or a setting mechanism such as cooling (chocolate, gelatin), heating, or crosslinking (alginate with calcium). Rheology, covered in food-physical-properties-rheology, is therefore the core science of food printing.
Applications include personalised nutrition, where shape, portion and nutrient content are tailored to an individual; texture-modified foods for people with swallowing difficulties (dysphagia), which can be printed into appealing shapes from purées; confectionery and chocolate shapes; and research into plant-based and cultivated meat structures, where printing can lay down protein, fat and, potentially, cells in a pattern resembling muscle and fat tissue. Printing is also used in research kitchens and for small-batch production.
The limits are speed, cost and scale: layer-by-layer deposition is slow compared with moulding, extrusion or forming, so printing suits high-value or customised products rather than commodities. Hygiene of nozzles and cartridges, microbial safety of moist pastes held at room temperature, post-printing cooking that can distort shapes, and the need for printable formulations are practical challenges. Claims that 3D printing will transform mass food production should be treated with caution. Food printers are also used to teach design and to prototype shapes before investment in moulds, which is one of their most practical uses in product development today.
Protein quality describes how well a protein meets human needs for indispensable amino acids, accounting for digestibility. The protein digestibility-corrected amino acid score (PDCAAS) multiplies the score of the most limiting amino acid (its content relative to a reference pattern) by faecal true protein digestibility and truncates values above 1.0. A protein whose limiting amino acid score is 0.85 with digestibility 0.90 has a PDCAAS of 0.85 × 0.90 = 0.77. An FAO expert consultation in 2013 recommended the digestible indispensable amino acid score (DIAAS), which uses ileal digestibility of each amino acid separately and is not truncated: DIAAS = 100 × the lowest ratio of digestible indispensable amino acid content in the food protein to that in the reference protein. If digestible lysine is 48 mg per g of protein against a reference of 57 mg per g, and lysine is limiting, DIAAS = 84. Plant proteins are commonly limited by lysine (cereals) or sulphur amino acids (legumes), and blends such as cereal with legume complement each other. Values depend on the reference pattern (age group) and on processing, which can improve or damage digestibility.
Replacing meat or milk with an alternative changes more than protein. Animal-source foods supply vitamin B12 (absent from plants), haem iron, zinc, iodine (milk), calcium (milk), vitamin D and long-chain omega-3 fatty acids (fish). Analogues must be fortified to match these, and the bioavailability of iron and zinc from plant matrices is reduced by phytate and polyphenols. Plant ingredients can carry anti-nutrients such as trypsin inhibitors, lectins, phytate and saponins, largely reduced by heating, soaking, fermentation or fractionation; pulses-oilseeds-plant-proteins covers them.
Many alternative protein products are highly processed and formulated, with added salt, fat and additives; whether such processing itself harms health, as debated under classifications of ultra-processed foods, is unresolved, and a technologist should distinguish evidence about specific nutrients and ingredients from generalisations about processing. Fortification and formulation can close many of these gaps, but they must be designed on evidence for the target population; adding nutrients that are poorly absorbed from the matrix, or relying on label claims without testing bioavailability, can leave consumers who switch completely at risk of deficiency, especially children, pregnant women and older people.
Novel protein sources raise specific safety questions. Allergenicity: new sources may introduce new allergens (pea, mung bean, lupin, insects, mycoprotein) or cross-reactivity, and precision-fermented animal proteins retain the allergenicity of the original, covered in food-toxicology-contaminants-allergens. Contaminants: heavy metals, mycotoxins and pesticide residues from crops and substrates; algal toxins; process contaminants. Microbiology: plant-based analogues are moist, near-neutral, protein-rich and often minced, so they support pathogens and spoilage like meat and need similar cold chain and cooking guidance. Novel processes: residual production organisms, DNA, media components, growth factors and scaffold materials in precision fermentation and cultivated meat must be characterised. Nutritional safety: high nucleic acid in single-cell protein, iodine in seaweed. Regulators assess these case by case. Some hazards are new in kind. Cultivated meat requires assessment of the genetic stability of cell lines over many divisions, residues of media components and growth factors, and microbial contamination during long culture; precision fermentation requires evidence that the production strain and its DNA are absent or harmless. FAO and WHO have published guidance on hazard identification for cell-based foods.
Most jurisdictions require pre-market authorisation of foods without a history of safe use. In the European Union, Regulation (EU) 2015/2283 defines a novel food as one not consumed to a significant degree in the Union before 15 May 1997; applications are assessed by EFSA and authorised by the Commission, with the authorisation listing conditions of use, specifications and labelling. Traditional foods from third countries with a documented history of safe use outside the EU have a simplified notification route. The United Kingdom has its own novel food system since leaving the EU. Genetically modified organisms used as food, or foods containing them, fall under separate GMO legislation in the EU, which matters for some precision fermentation products.
In the United States, many new ingredients enter the market through the generally recognised as safe (GRAS) process, in which the producer establishes and can notify the FDA of a safety conclusion, while food additives and colour additives require FDA approval. Cultivated meat and poultry are regulated jointly: FDA oversees cell collection, banking and growth, and USDA's Food Safety and Inspection Service oversees harvest, processing and labelling. Singapore's Food Agency set up one of the first specific frameworks for novel foods, including cultivated meat. Many other countries and regions have their own pre-market approval systems for novel foods and new ingredients, generally built on the risk assessment principles of Codex Alimentarius: a safety dossier is reviewed by a national authority before the product may be sold.
Labelling questions are as contested as safety questions. Should plant-based products use names such as 'milk', 'burger' or 'sausage'? The EU restricts dairy names to animal milk products, with exceptions, but rejected a proposal to ban meat names for plant products; national rules in some member states and other countries have attempted such bans, with differing outcomes in courts. Cultivated meat labelling terms (cultivated, cell-based, cultured, lab-grown) are debated, and regulators in some jurisdictions have required a qualifying term. Precision-fermented proteins raise questions about calling a product 'animal-free' while declaring a milk allergen. Health and environmental claims on these products are subject to general rules on claims and on misleading advertising.
Because frameworks and decisions change rapidly, a technologist should always confirm the current status of any ingredient or product in each target market, rather than relying on a textbook or news report. The labels of novel foods must also carry any conditions set in their authorisation, such as warnings for allergic consumers or restrictions on use by particular groups, and products must not claim health benefits that have not been authorised under the relevant claims rules.
Life-cycle assessment (LCA) quantifies the environmental impacts of a product across its life cycle, following the ISO 14040 and 14044 standards. It has four phases: goal and scope definition (including the functional unit and system boundaries), life-cycle inventory (the inputs and emissions at each stage), impact assessment (converting inventory into impact categories such as climate change, land use, water use, eutrophication and acidification) and interpretation. System boundaries may be cradle-to-gate (to the factory gate) or cradle-to-grave (including retail, home preparation and waste). Attributional LCA describes the impacts attributed to a product in an existing system; consequential LCA estimates the change in impacts caused by a decision, such as replacing beef with an analogue, including indirect effects on markets and land use. Results depend strongly on these choices, on data sources and on allocation of impacts between co-products. Data quality matters. Primary data from a specific plant are more reliable than generic database values, and prospective studies of technologies not yet built at scale carry large uncertainties that should be reported, not hidden.
The functional unit defines what is being compared. Per kilogram of product favours dilute products; per kilogram of protein, per unit of protein quality or per nutrient-density score can change the ranking. A product with 2.0 kg CO2-equivalent per kg and 20% protein emits 2.0 ÷ 0.20 = 10 kg CO2e per kg protein; one with 25 kg CO2e per kg and 26% protein emits 96 kg per kg protein, about 9.6 times more per unit protein. Comparisons must also match like with like: an analogue should be compared with the specific meat it replaces, from a stated production system and country, because livestock impacts vary severalfold between systems.
Published LCAs commonly find that plant-based analogues and pulses have much lower greenhouse gas emissions and land use per kg of protein than beef and lamb, with smaller differences against chicken, pork, eggs and dairy; the size of the difference varies widely between studies. For cultivated meat, prospective LCAs find results dominated by energy use, so impacts may be lower than beef only if production is efficient and powered by low-carbon energy, and may exceed those of chicken or pork otherwise; these are modelled rather than measured at commercial scale.
Sustainability claims on alternative protein products should be judged critically. Ask what functional unit and system boundary were used, whether the comparison product and system are specified, whether the study was independent or peer reviewed, how sensitive the result is to energy source and yields, and which impact categories were included: a product can be better on climate but worse on water or energy. Biodiversity, soil health, animal welfare, livelihoods and nutrition are not captured by most LCAs. Regulators in several jurisdictions, including the European Union, are tightening rules on generic environmental claims such as 'eco-friendly' or 'climate neutral', requiring them to be substantiated. A precise, evidence-based statement, such as a stated reduction in greenhouse gas emissions per kg of protein against a named comparison in a cited study, is more defensible than a sweeping claim. Sustainability also has social and economic dimensions. Shifts in protein supply affect the livelihoods of livestock farmers, fishers and crop growers, and the benefits and costs of new technologies are not evenly shared between countries.
A student uses this subject to understand the newest part of food technology and to answer the questions that do appear: how plant drinks and TVP are made, how high-moisture extrusion creates fibres, how PDCAAS and DIAAS are calculated, and why fortification matters. In the laboratory the student can make a soy or oat drink, extrude or shear a plant protein, compare its texture with meat, and calculate protein quality and the carbon footprint per kg protein from given data. Knowing the evidence behind claims also prepares the student for interviews in a sector where hype is common.
Five years into an alternative protein company or a food manufacturer's R&D team, a technologist formulates analogues against a meat or dairy target, selects protein ingredients by functionality and flavour, runs extrusion or fermentation trials, designs shelf-life and cooking studies, builds the nutrition panel and fortification plan, and prepares the safety and regulatory dossier, checking allergens, novel food status and naming rules in each market. The same person must be able to defend sustainability claims with a credible LCA. Working closely with regulatory, marketing and sensory colleagues is part of the role.
After twenty-five years a senior leader decides which protein routes to invest in, judging technology readiness, cost at scale, regulatory risk and consumer acceptance; builds supply chains for new crops and fermentation capacity; responds to shifting markets and labelling disputes; and keeps claims honest when marketing pressure is high. The leader also weighs hybrid strategies that combine plant, fermentation and animal ingredients rather than betting on one route. The leader also answers to investors and regulators for the accuracy of every nutrition, safety and environmental claim the company makes, and sets the culture that keeps those claims evidence-based.
A researcher with long industry experience works on the hard scientific problems: protein structuring and flavour chemistry in analogues, strain and process engineering for precision fermentation, low-cost serum-free media and scalable bioreactors for cultivated cells, protein quality and bioavailability of new sources, allergenicity assessment, and rigorous prospective and consequential LCA. Such work builds the evidence that regulators, investors and the public need to separate real advances from hype. Collaboration across disciplines, from cell biology to life-cycle modelling, is the norm, and so is publishing negative results that temper unrealistic expectations.
This manual gives principles and dated examples in a fast-moving field. It does not track current approvals, market sizes, company products or prices, which change monthly; regulatory status must be confirmed in each market. Environmental figures are given only as relative, LCA-dependent comparisons and a worked normalisation, not as definitive numbers. Detailed bioprocess engineering of cell culture and precision fermentation, genetic engineering methods, protein chemistry of each crop, extrusion engineering and the general food law system are covered in fermentation-food-biotechnology, pulses-oilseeds-plant-proteins, extrusion-technology and food-law-regulatory-affairs. Consumer science and economics of alternative proteins are treated only briefly, and long-term health outcomes of most new products are not yet known.
Original practice questions written to the syllabus and pattern of the exams named in each question's examTags. They are not past papers and do not reproduce any board's questions. Every numerical answer was computed by script. This is a fast-moving field: regulatory facts are dated, and environmental figures in questions are illustrative inputs, not definitive values.
These notes are free to read here, with no account.
What the Laisha app adds:
Free for ten days, then a subscription. We would rather write that here than have you find it later.